AEON: the balance sheet

MyFinsight

For the quarter ending 2025-09-30, AEON has $8,734K in assets. $28,606K in debts. $5,927K in cash and cash equivalents.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Balance Sheets	2025-09-30	2025-06-30
Cash and cash equivalents	5,927	8,439
Prepaid expenses and other current assets	1,485	1,823
Total current assets	7,412	10,262
Property and equipment, net	181	200
Operating lease right-of-use asset	1,112	1,171
Other assets	29	29
Total assets	8,734	11,662

Accounts payable	2,525	3,907
Accrued clinical trials expenses	1,524	1,675
Accrued compensation	1,547	546
Other accrued expenses	2,632	3,001
Total current liabilities	8,228	9,129
Convertible notes at fair value, including related party amount of 17,051 and 11,689, at september 30, 2025 and december 31, 2024, respectively	17,051	15,174
Operating lease liability	957	1,020
Contingent consideration liability	-	100
Warrant liability	2,338	2,122
Contingent consideration liability	32	69
Total liabilities	28,606	27,514
Class a common stock, 0.0001 par value 1,040,000,000 and 500,000,000 shares authorized at september 30, 2025 and december 31, 2024, and 11,643,786 and 555,511 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively	9	9
Additional paid-in capital	413,801	413,283
Accumulated deficit	-433,682	-429,144
Total stockholders' deficit	-19,872	-15,852
Total liabilities and stockholders' deficit	8,734	11,662

Unit: Thousand (K) dollars